Taub Rebecca 4

Accession 0001628280-26-003452

CIK 0001157601other

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 5:05 PM ET

Size

6.1 KB

Accession

0001628280-26-003452

AI-generated summary of this filing

Updated Jan 26, 2026

Madrigal (MDGL) Director Rebecca Taub Sells 647 Shares

What Happened

Rebecca Taub, a director of Madrigal Pharmaceuticals (MDGL), had 647 shares sold on 2026-01-26 at $492.42 per share, generating $318,596. The sale was executed to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs).

Key Details

Transaction date and price: 2026-01-26, 647 shares at $492.42 each.
Total proceeds: $318,596 (gross).
Shares owned after the transaction: Not specified in the filing.
Footnotes: The sale was automatic and executed by the issuer on behalf of the reporting person to satisfy tax withholding (sell-to-cover). The reporting person and her spouse are managing members of SQN, LLC; she disclaims beneficial ownership of securities held by SQN except to the extent of any pecuniary interest.
Filing timeliness: Reported on 2026-01-26 (same day as the transaction), indicating a timely Form 4 filing.

Context

This was a routine sell-to-cover tied to RSU vesting rather than an opportunistic open-market trade; such automatic sales are commonly used solely to satisfy tax withholding and do not necessarily signal the insider’s view on the company.

Form 4

Period: 2026-01-26

Director

Transactions

Holdings

Footnotes (2)

[F1]This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
[F2]The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Signature

/s/ Mardi Dier, as Attorney-in-Fact|2026-01-26

1 file

MADRIGAL PHARMACEUTICALS, INC.

CIK 0001157601

Entity typeother